Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy

Adnan Kastrati*, Nicolas Von Beckerath, Alexander Joost, Gisela Pogatsa-Murray, Olga Gorchakova, Albert Schömig

*Korrespondierende/r Autor/-in für diese Arbeit
189 Zitate (Scopus)

Abstract

Background - It is not known whether further suppression of platelet function can be achieved with clopidogrel beyond that provided by currently recommended loading and maintenance doses. We performed a comparative assessment of the antiplatelet effects of a 600-mg loading dose of clopidogrel given to patients with and without chronic clopidogrel therapy. Methods and Results - Those eligible for this prospective study were aspirin-treated patients with suspected or documented coronary artery disease admitted to hospital for coronary angiography. Two series of 20 consecutive patients each were assessed in this study. The first series included patients who had never received clopidogrel (first-use group); the second series included patients on chronic therapy with a daily dose of 75 mg clopidogrel for ≥ month (chronic therapy group). Blood samples were drawn before and 6 hours after oral administration of 600 mg clopidogrel for aggregometry and flow cytometry studies. In the first-use group, loading with 600 mg clopidogrel inhibited ADP 5 mol/L-induced platelet aggregation from 90±9% to 51±19% (P<0.001). In the chronic therapy group, loading with 600 mg clopidogrel yielded further inhibition of ADP 5 μmol/L-induced platelet aggregation in addition to that achieved by the maintenance dose of 75 mg/d, from 52±14% to 33±12% (P<0.001). In both groups, 600 mg clopidogrel loading significantly inhibited ADP-induced expression of glycoprotein IIb/IIIa and P-selectin receptors. Conclusions - Further platelet inhibition can be achieved with clopidogrel in addition to that provided by currently recommended loading and maintenance doses. Higher doses may be warranted after assessment of their clinical efficacy and safety.

OriginalspracheEnglisch
ZeitschriftCirculation
Jahrgang110
Ausgabenummer14
Seiten (von - bis)1916-1919
Seitenumfang4
ISSN0009-7322
DOIs
PublikationsstatusVeröffentlicht - 05.10.2004

Fingerprint

Untersuchen Sie die Forschungsthemen von „Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren